Patents by Inventor Michiel Onne Elema

Michiel Onne Elema has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE COMPOSITION CONTAINING ESCITALOPRAM
    Publication number: 20080305164
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Application
    Filed: August 22, 2008
    Publication date: December 11, 2008
    Applicant: H. LUNDBECK A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Crystalline composition containing escitalopram
    Patent number: 7420069
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Grant
    Filed: February 7, 2005
    Date of Patent: September 2, 2008
    Assignee: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Controlled agglomeration
    Patent number: 7217431
    Abstract: A process for the preparation of a particulate material by a controlled agglomeration method, i.e. a method that enables a controlled growth in particle size. The method is especially suitable for use in the preparation of pharmaceutical compositions containing a therapeutically and/or prophylactically active substance which has a relatively low aqueous solubility and/or which is subject to chemical decomposition. The process comprising i) spraying a first composition comprising a carrier, which has a melting point of about 5° C. or more which is present in the first composition in liquid form, on a second composition comprising a material in solid form, the second composition having a temperature of at the most a temperature corresponding to the melting point of the carrier and/or the carrier composition and ii) mixing or others means of mechanical working the second composition onto which the first composition is sprayed to obtain the particulate material.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: May 15, 2007
    Assignee: LifeCycle Pharma A/S
    Inventors: Per Holm, Anders Buur, Michiel Onne Elema, Birgitte Møllgaard, Jannie Egeskov Holm, Kirsten Schultz
  • Crystalline composition containing escitalopram
    Patent number: 6916941
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: July 12, 2005
    Assignee: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Crystalline composition containing escitalopram
    Publication number: 20030212128
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 &mgr;m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Application
    Filed: March 31, 2003
    Publication date: November 13, 2003
    Applicant: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Melt granulated composition and modified release dosage form prepared from said composition
    Publication number: 20020160050
    Abstract: Solid modified release dosage forms, prepared from melt granulated compositions comprising (A) one or more hydrophilic cellulose ether polymers, (B) a hydrophilic melt binder, and (C) a therapeutically active ingredient.
    Type: Application
    Filed: March 25, 2002
    Publication date: October 31, 2002
    Applicant: H. Lundbeck A/S
    Inventors: Michiel Onne Elema, Per Holm